CAH on NYSE

Cardinal Health

Logo: Cardinal Health, Public domain, via Wikimedia Commons5

American multinational health care services company

Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations.3 From Wikipedia, CC BY-SA 4.0

$253.46 up 5.72 (2.31%)Price as of Oct 15, 2026 at 19:45 UTC

Last updated Oct 16, 2026.

Overview

$254.2BRevenue, fiscal 20266
$1.7BNet income, fiscal 20266
1971Founded1

Compare with Cencora, McKesson Corporation or Herbalife, or pick any stock.

  • TickerCAH on NYSE1
  • Industryhealth care1
  • HeadquartersDublin1
  • Websitewww.cardinalhealth.com
  • Incorporated inOH7
  • Business address7000 Cardinal Place, Dublin, Oh 430177
  • Filer categoryLarge accelerated filer7
Cardinal Health headquarters (Dublin, Ohio)
Photo: Nheyob, CC BY-SA 4.0, via Wikimedia Commons9

Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

3.8%Gross margin6
1.0%Operating margin6
0.7%Net margin6
14.2%Revenue growth, 20266
$4.5BFree cash flow6

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Pharmaceutical and Specialty Solutions brought in 92% of the revenue Cardinal Health broke down this way in fiscal 2026.

  1. Pharmaceutical and Specialty Solutions$234.8B692%up 15% from 2025
  2. GMPD$12.7B65%up 1% from 2025
  3. Other Operating$6.8B63%up 26% from 2025
Business segments by year
Business segments202420252026
Pharmaceutical and Specialty Solutions$210.0B$204.6B$234.8B
GMPD$12.4B$12.6B$12.7B
Other Operating$4.5B$5.4B$6.8B

Regions

United States brought in 99% of the revenue Cardinal Health broke down this way in fiscal 2026.

  1. United States$252.6B699%up 14% from 2025
  2. Outside the United States$1.7B61%up 2% from 2025
Regions by year
Regions202420252026
United States$225.2B$221.0B$252.6B
Outside the United States$1.7B$1.7B$1.7B

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue97¢$244.5B
  • Selling, general and admin2¢$6.1B
  • Interest0¢$348.0M
  • Income tax0¢$469.0M
  • Profit1¢$1.7B

Out of $254.2B in revenue.6

Where each dollar of operating cash went, fiscal 2026

  • Capital spending13¢$649.0M
  • Dividends paid9¢$491.0M
  • Share buybacks26¢$1.4B
  • Kept or used elsewhere52¢$2.7B

Out of $5.2B of cash from operations.6

Financial statements

Revenue10111213146$254.2B in 2026+75% since 2019
0$100.0B$200.0B$300.0B2019: $145.5B$145.5B20192020: $152.9B$152.9B2020+5%2021: $162.5B$162.5B2021+6%2022: $181.3B$181.3B2022+12%2023: $205.0B$205.0B2023+13%2024: $226.8B$226.8B2024+11%2025: $222.6B$222.6B2025−2%2026: $254.2B$254.2B2026+14%
Gross profit10111213146$9.8B in 2026+43% since 2019
0$2.5B$5.0B$7.5B$10.0B2019: $6.8B$6.8B20192020: $6.9B$6.9B2020+0%2021: $6.8B$6.8B2021−1%2022: $6.5B$6.5B2022−4%2023: $6.9B$6.9B2023+6%2024: $7.4B$7.4B2024+8%2025: $8.2B$8.2B2025+10%2026: $9.8B$9.8B2026+20%
Operating income10111213146$2.6B in 2026+27% since 2019
-$6.0B-$4.0B-$2.0B0$2.0B$4.0B2019: $2.1B$2.1B20192020: -$4.1B-$4.1B20202021: $472.0M$472.0M20212022: -$607.0M-$607.0M20222023: $752.0M$752.0M20232024: $1.2B$1.2B2024+65%2025: $2.3B$2.3B2025+83%2026: $2.6B$2.6B2026+15%
Net income10111213146$1.7B in 2026+26% since 2019
-$4.0B-$2.0B0$2.0B2019: $1.4B$1.4B20192020: -$3.7B-$3.7B20202021: $611.0M$611.0M20212022: -$938.0M-$938.0M20222023: $330.0M$330.0M20232024: $852.0M$852.0M2024+158%2025: $1.6B$1.6B2025+83%2026: $1.7B$1.7B2026+10%

Every line of the income statement in the latest annual report, as filed.6

Period ending2026-06-302025-06-302024-06-30
Revenue$254.2B$222.6B$226.8B
Cost of products sold$244.5B$214.4B$219.4B
Gross margin$9.8B$8.2B$7.4B
Distribution, selling, general, and administrative expenses$6.1B$5.4B$5.0B
Restructuring and employee severance$106.0M$88.0M$175.0M
Amortization and other acquisition-related costs$469.0M$464.0M$284.0M
Acquisition-related cash and share-based compensation costs [Line Items]$287.0M$126.0M$0
Impairments and (gain)/loss on disposal of assets, net$177.0M$18.0M$634.0M
Litigation (recoveries)/charges, net-$10.0M-$185.0M$78.0M
Operating earnings$2.6B$2.3B$1.2B
Other (income)/expense, net-$31.0M-$41.0M-$9.0M
Interest expense, net$348.0M$215.0M$51.0M
Equity Method Investment, Other-than-Temporary Impairment$122.0M$0$0
Earnings before income taxes$2.2B$2.1B$1.2B
Income Tax Expense (Benefit)$469.0M$532.0M$348.0M
Net earnings$1.7B$1.6B$853.0M
Less: Net (earnings)/loss attributable to noncontrolling interests$9.0M-$8.0M-$1.0M
Net earnings attributable to Cardinal Health, Inc.$1.7B$1.6B$852.0M
Basic (in dollars per share)$7.27$6.48$3.48
Diluted (in dollars per share)$7.23$6.45$3.45
Basic (in shares)236.0M shares241.0M shares245.0M shares
Diluted (in shares)237.0M shares242.0M shares247.0M shares

Compare Cardinal Health with another company

The story

Founded by Robert D. Walter in 1971.1

History

Founded in 1971 as Cardinal Foods by Robert D. Walter, the company was initially a food wholesaler. After acquiring the Bailey Drug Company in 1979, it began whole selling drugs. The company went public on the NASDAQ stock exchange in 1983.

In 1988, Walter sold Cardinal Health's food operations to Roundy's. From 1991 to 1996, the company's sales grew from $1.2 billion to $8.9 billion. The company changed its name to Cardinal Health in 1994, and became the third-largest pharmaceutical wholesaler in the United States.

2000–2019

R. Kerry Clark, a former executive and vice chairman at Procter & Gamble, was appointed president and CEO in April 2006, with Robert D. Walter retaining Chairmanship of the board. In September 2008, the company announced Clark and Walter would retire and George S. Barrett would become the chairman and CEO.

In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called CareFusion with David Schlotterbeck as CEO. Cardinal Health is now traded on the NYSE under symbol CAH.

In December 2013, it was announced that Cardinal Health would partner with CVS Caremark to form a generic drug sourcing operation in the United States. The venture was named Red Oak Sourcing and began operations in July 2014.

Between 2014 and 2016, Cardinal, alongside McKesson Corporation, and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in April 2016.

In January 2018, Michael Kaufmann assumed the role of CEO after serving as CFO of the company.

Opioid lawsuits

In 2019, Cardinal was one of several drug distributors named in lawsuits related to the opioid crisis in the US. In July 2021, Cardinal Health and other pharmaceutical companies agreed to participate in a $26 billion settlement. Cardinal will pay $6.4 billion over 18 years.

Read the full text

In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against AmerisourceBergen and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."

2020–present

As of August 2021, it is ranked 14 on the Fortune 500 list with FY2020 annual revenue of $152.9 billion. The firm employs 57,000 people worldwide.

Acquisitions

In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired. The merger represented the first non-distribution acquisition by Cardinal Health.

In 1996, Cardinal Health acquired Pyxis Corporation, a company that developed automated pill dispensers for hospitals, for $867 million.

In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which McKesson Corporation responded with a bid to purchase Amerisource. Instead, Amerisource and Bergen merged into AmerisourceBergen. Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time.

In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of Baxter Healthcare). In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in Indianapolis.

In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million. In June 2007, the firm announced the completion of a tender offer for VIASYS Healthcare.

In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million. In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent. From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor. Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.

On March 18, 2013, Cardinal Health acquired the Twinsburg, Ohio-based privately held medical supply distributor AssuraMed, and with it its subsidiaries including Edgepark Medical Supplies, for $2.7 billion. AssuraMed was backed by private equity firms Clayton, Dubilier & Rice and Goldman Sachs Alternatives.

In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States. The companies started buying generic drugs around the world to sell in U.S. markets.

In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion. The acquisition was completed on October 4, 2015. Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion.

In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from Medtronic for $6.1 billion. The acquisition was completed on July 30, 2017.

In November 2024, Cardinal Health announced the plan to acquire Advanced Diabetes Supply Group (ADSG), a leading national direct-to-patient provider of diabetes medical supplies, for about $1.1 billion with plans to merge the company into its at-Home Solutions business. The at-Home Solutions business includes Edgepark Medical Supplies of Twinsburg, Ohio and United States Medical Supply (US MED) of Doral, Florida. The acquisition was complete by April 2024.

In August 2025, Cardinal Health announced that it would acquire a 75% stake in Solaris Health, the largest urology management services organization (MSO) in the United States, for $1.9 billion in cash.

In July 2026, Cardinal Health agreed to acquire AdaptHealth's diabetes health business and medical-supply provider Strive Medical in separate transactions worth approximately US$360 million in total. The acquisitions were intended to expand its at-Home Solutions business in diabetes and urological care.

Cardinal Health Foundation

The Cardinal Health Foundation is the charitable arm of Cardinal Health. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. In 2008, the foundation established its E3 Grant Program. Over the past seven years, the Foundation has invested more than $7.15 million in funding to 241 hospitals, health systems or other health-related organizations.

Cardinal Health also supports organizations such as Ronald McDonald House Charities, and was named Benefactor of the Year at the 2011 Corporate Caring Awards. In 2015, the foundation contributed $3 million to the Solutions for Patient Safety project, which has raised over $11 million nationally for efforts to improve safety initiatives in children's hospitals.

From Wikipedia’s article on Cardinal Health, shared under CC BY-SA 4.0.8

Leadership

Who has led Cardinal Health, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (16)

Subsidiaries and ownership

Subsidiaries

  • Cardinal Health (Australia)
  • Cardinal Health (Switzerland)

From Wikidata.1

Former names

  • CARDINAL HEALTH INCAug 19, 1994 to Oct 1, 20267
  • CARDINAL DISTRIBUTION INCFeb 16, 1994 to Feb 17, 19947

Timeline

  1. 1971Founded Founded1

Recent filings

  1. Oct 1, 20268-K
  2. Sep 21, 2026DEF 14A DEFINITIVE PROXY STATEMENT
  3. Sep 21, 2026DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
  4. Sep 21, 2026ARS ANNUAL REPORT TO SECURITY HOLDERS
  5. Aug 20, 20264
  6. Aug 20, 20264
  7. Aug 20, 20264
  8. Aug 20, 20264
  9. Aug 20, 20264
  10. Aug 20, 20264
  11. Aug 20, 20264
  12. Aug 19, 2026144
  13. Aug 18, 20264
  14. Aug 18, 20264
  15. Aug 18, 20264

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2